The UK’s National Institute for Health and Care Excellence (NICE) has recommended medtech giant Abbott’s heart failure sensor CardioMEMS.

This means that the CE-marked medical device will be available for routine use within the National Health Service (NHS) in adult patients with chronic heart failure. CardioMEMS is specifically recommended for those who have been previously hospitalised due to heart failure and are at continued risk.

The UK health watchdog’s recommendation of Abbott’s heart failure device falls in line with the government’s 10 Year Health Plan, which aims to use transformative technologies to reduce pressure on healthcare systems and shift the care paradigm to a more home-based model.